← Eichor
Study identifier: NCT07501663 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Optimizing Integrative Oncology Approaches to Address Chemotherapy-induced Peripheral Neuropathy in Gastrointestinal (GI) Cancer Patients: A SMART Pilot Study

Condition: Peripheral Neuropathy  ·  Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The objective of the proposed pilot is to test the feasibility, acceptability, and preliminary efficacy of a 16-week sequential, multiple assessment randomized trial (SMART), which includes virtual Tai Chi/Qi Gong or α- Lipoic acid (ALA) supplements as an initial treatment, and acupuncture as the additional treatment, that examines a stepped-care intervention to address CIPN.

This description comes directly from the study's public registry record.

Talk to the study team

Kuang-Yi Wen, PhD  ·  215-503-4623  ·  Kuang-Yi.Wen@Jefferson.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Sidney Kimmel Cancer Center at Thomas Jefferson UniversityPhiladelphia, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07501663